Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

CM Alvim Impl Ti 4.3X13: medical device reports filed with FDA

853 reports name it, 2018–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

853
device reports naming the brand
0% of all MAUDE reports · about 100 a year
60
reports, 12 months to August 2026
114 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 853 reports that name the brand "CM Alvim Impl Ti 4.3X13" (endosseous dental implant), received between January 2018 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

60 reports arrived in the 12 months to August 2026, down 47% from 114 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (87%), loss of osseointegration (6.1%) and fracture (0.7%). The patient problems coded most often are pain, fibrosis and swelling/ edema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04385Sep 2021: 3Oct 2021: 6Nov 2021: 9Dec 2021: 42022Jan 2022: 2Feb 2022: 1Mar 2022: 5Apr 2022: 16May 2022: 16Jun 2022: 10Jul 2022: 3Aug 2022: 34Sep 2022: 13Oct 2022: 54Nov 2022: 36Dec 2022: 82023Jan 2023: 85Feb 2023: 10Mar 2023: 8Apr 2023: 39May 2023: 50Jun 2023: 9Jul 2023: 6Aug 2023: 16Sep 2023: 5Oct 2023: 5Nov 2023: 6Dec 2023: 132024Jan 2024: 2Feb 2024: 1Mar 2024: 1Apr 2024: 4May 2024: 5Jun 2024: 10Jul 2024: 23Aug 2024: 62Sep 2024: 30Oct 2024: 26Nov 2024: 18Dec 2024: 52025Jan 2025: 10Feb 2025: 1Mar 2025: 3Apr 2025: 0May 2025: 0Jun 2025: 17Jul 2025: 4Aug 2025: 0Sep 2025: 2Oct 2025: 6Nov 2025: 3Dec 2025: 112026Jan 2026: 5Feb 2026: 4Mar 2026: 9Apr 2026: 2May 2026: 4Jun 2026: 7Jul 2026: 4Aug 2026: 3

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01262522018: 520182019: 1120192020: 4320202021: 6220212022: 19820222023: 25220232024: 18720242025: 5720252026: 382026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%853
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report97.4%831
Voluntary report0%0
User facility report0%0
Distributor report2.6%22
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate74287%62.8%
Loss of osseointegration526.1%22.4%
Fracturea broken bone60.7%1.6%
Difficult to insertthe device was hard to insert20.2%0.4%
Separation failure10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified9210.8%
Fibrosis657.6%
Swelling/ edema222.6%
Hemorrhage/blood loss/bleeding202.3%
Inflammationinflammation192.2%
Tissue damage161.9%
Fistula141.6%
Hyperresponsive to stimuli80.9%
Abscessa collection of pus50.6%
Increased sensitivity30.4%
Sinus perforation20.2%
Failure of implant10.1%
Inadequate osseointegration10.1%
Swellingswelling10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCM Alvim Impl Ti 4.3X13Product code DZEAll MAUDE reports
Reports8533,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer97.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about CM Alvim Impl Ti 4.3X13 reports

How many FDA reports name CM Alvim Impl Ti 4.3X13?

853 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 60 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (87%), loss of osseointegration (6.1%), fracture (0.7%), difficult to insert (0.2%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (97.4%) and distributor reports (2.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that CM Alvim Impl Ti 4.3X13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.